Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of Etoricoxib 60 mg vs 90 mg vs Placebo in Rheumatoid Arthritis
2010-019871-31Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of etoricoxib in rheumatoid arthritis (RA) (3 arms), sponsored by Merck & Co. Primary endpoints: Primary Hypothesis 1 and Primary Hypothesis 2. Started Aug 2010; status: completed.
02
Drugs
etoricoxib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-019871-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019871-31.